3d3 Search Results


94
Developmental Studies Hybridoma Bank primary antibodies
Primary Antibodies, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

h7n3  (ATCC)
96
ATCC h7n3
LAIV did not induce <t>anti-H7N3</t> HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.
H7n3, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h7n3/product/ATCC
Average 96 stars, based on 1 article reviews
h7n3 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech rabbit anti human aeg
LAIV did not induce <t>anti-H7N3</t> HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.
Rabbit Anti Human Aeg, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human aeg/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti human aeg - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
OriGene rc207238
LAIV did not induce <t>anti-H7N3</t> HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.
Rc207238, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rc207238/product/OriGene
Average 90 stars, based on 1 article reviews
rc207238 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Novus Biologicals anti podocalyxin
LAIV did not induce <t>anti-H7N3</t> HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.
Anti Podocalyxin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti podocalyxin/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti podocalyxin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

92
BOC Sciences l tryptophan 2 3 3 d3
LAIV did not induce <t>anti-H7N3</t> HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.
L Tryptophan 2 3 3 D3, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l tryptophan 2 3 3 d3/product/BOC Sciences
Average 92 stars, based on 1 article reviews
l tryptophan 2 3 3 d3 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

93
Novus Biologicals hk2
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
Hk2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hk2/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
hk2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

92
CDN Isotopes propionic 3 3 3 d3 acid
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
Propionic 3 3 3 D3 Acid, supplied by CDN Isotopes, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/propionic 3 3 3 d3 acid/product/CDN Isotopes
Average 92 stars, based on 1 article reviews
propionic 3 3 3 d3 acid - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

92
Novus Biologicals 3d3 novus biologicals nbp2
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
3d3 Novus Biologicals Nbp2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3d3 novus biologicals nbp2/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
3d3 novus biologicals nbp2 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

93
Cambridge Isotope Laboratories 2 3 3 acrylamide d3
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
2 3 3 Acrylamide D3, supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2 3 3 acrylamide d3/product/Cambridge Isotope Laboratories
Average 93 stars, based on 1 article reviews
2 3 3 acrylamide d3 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Chem Impex International tert butyl 4 amino
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
Tert Butyl 4 Amino, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tert butyl 4 amino/product/Chem Impex International
Average 95 stars, based on 1 article reviews
tert butyl 4 amino - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology yellow 54
Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and <t>HK2</t> (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.
Yellow 54, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/yellow 54/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
yellow 54 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


LAIV did not induce anti-H7N3 HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.

Journal: Saudi Journal of Biological Sciences

Article Title: Live attenuated influenza vaccine induces broadly cross-reactive mucosal antibody responses to different influenza strains in tonsils

doi: 10.1016/j.sjbs.2023.103809

Figure Lengend Snippet: LAIV did not induce anti-H7N3 HA IgG antibody production. No significant level of specific anti-HA IgG antibody to H7N3 was detected compared with unstimulated cells (n = 15, p > 0.05). Means and standard errors are shown.

Article Snippet: Purified recombinant HA proteins of pH1N1 (A/California/04/2009,VR-1894DQ),sH1N1 (A/Brisbane/59/2007, VR-1742), sH3N2 (A/Brisbane/10/2007, VR-1881), aH5N1 (A/Vietnam/1203/2004, VR-1931), A/Hong Kong/8/68, VR-1679), and H7N3 (A/Canada/RV444/04, VR-1641) were from Biodefense and Emerging Infections Research Resources Repository (BEI resources ATCC (Manassas VA, USA).

Techniques:

Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and HK2 (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo.

doi: 10.1073/pnas.2220334120

Figure Lengend Snippet: Fig. 4. Zn treatment reverses ESCC metabolic phenotype in ZD rats. (A) Metabolomic profiling by GC-TOF MS on Zn-treated vs. Zn-untreated rat esophagus. A metabolomic network among the structurally identified metabolites was constructed (using the KEGG databases and PubChem compound identification [CID]) showing 14 up- and 24 downregulated metabolites. Each labeled node represents an identified and significantly altered metabolite (P < 0.05, t test; n = 10 rats per group). Blue and red nodes are significantly decreased and increased metabolites. The size of the nodes represents the size of the fold-change (Zn-treated vs. untreated). Blue lines are edges connected due to Tanimoto similarity; red lines are edges connected through KEGG reaction pairs. (B) Box and whisker plot (with median denoted by the line through the box and whiskers representing values within 1.5 IQR of the first and third quartile) showing distribution of putrescine and glucose metabolic activities and significantly reduced putrescine (P = 0.02) and increased glucose levels (P = 0.02) in Zn-treated vs. Zn-untreated esophagus. (C) IHC analysis of metabolite enzymes ODC (rate-limiting enzyme that converts ornithine to putrescine) expression and HK2 (rate-limiting enzyme and first obligatory step of glucose metabolism) expression in Zn-treated vs. Zn-untreated rat esophagus Representative esophageal photo showing moderate to strong immunostaining for ODC and HK2 in Zn-untreated esophagus as compared to weak and diffuse staining for the same protein in Zn-treated esophagus. HK2 and ODC expression (brown, 3,3′-diaminobenzidine tetrahydrochloride, DAB, counterstain, Harris modified hematoxylin). (D) Box and whisker plot showing distribution of ODC and HK2 immunoreactive score and significantly reduced ODC and reduced HK2 protein expression (P < 0.001) in Zn-treated vs. Zn-untreated esophagus.

Article Snippet: IHC was performed using primary antibodies for PCNA (clone PC-10, Ab-1, Thermo Scientific), COX-2 (#12282, Cell Signaling), S100A8 (T-1032, BMA, Augst, Switzerland), S100A9 (NB110-89726, Novus Biologicals), NF-κΒ p65 (ab7970, Abcam), STK40 (orb101780, Biorbyt), EGLN3 (orb443107, Biorbyt), PDCD4 (LS-B1388, Lifespan Biosciences, Seattle, WA), BAX (#14796, rabbit mAb, Cell Signaling), HK2 (NBP1-51643, Novus Biologicals), and ODC1 (NBP2-32887, Novus Biologicals).

Techniques: Construct, Labeling, Whisker Assay, Expressing, Immunostaining, Staining, Modification